1. Home
  2. BCLI vs BMTX Comparison

BCLI vs BMTX Comparison

Compare BCLI & BMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • BMTX
  • Stock Information
  • Founded
  • BCLI 2000
  • BMTX 2015
  • Country
  • BCLI United States
  • BMTX United States
  • Employees
  • BCLI N/A
  • BMTX 200
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BMTX Major Banks
  • Sector
  • BCLI Health Care
  • BMTX Finance
  • Exchange
  • BCLI Nasdaq
  • BMTX Nasdaq
  • Market Cap
  • BCLI 37.7M
  • BMTX 34.6M
  • IPO Year
  • BCLI N/A
  • BMTX N/A
  • Fundamental
  • Price
  • BCLI $0.38
  • BMTX $2.90
  • Analyst Decision
  • BCLI Strong Buy
  • BMTX Strong Buy
  • Analyst Count
  • BCLI 1
  • BMTX 3
  • Target Price
  • BCLI $2.00
  • BMTX $6.75
  • AVG Volume (30 Days)
  • BCLI 527.3K
  • BMTX 50.7K
  • Earning Date
  • BCLI 08-12-2024
  • BMTX 08-20-2024
  • Dividend Yield
  • BCLI N/A
  • BMTX N/A
  • EPS Growth
  • BCLI N/A
  • BMTX N/A
  • EPS
  • BCLI N/A
  • BMTX N/A
  • Revenue
  • BCLI N/A
  • BMTX $57,949,000.00
  • Revenue This Year
  • BCLI N/A
  • BMTX $15.52
  • Revenue Next Year
  • BCLI N/A
  • BMTX $5.19
  • P/E Ratio
  • BCLI N/A
  • BMTX N/A
  • Revenue Growth
  • BCLI N/A
  • BMTX N/A
  • 52 Week Low
  • BCLI $0.13
  • BMTX $1.41
  • 52 Week High
  • BCLI $1.90
  • BMTX $3.91
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 45.44
  • BMTX 58.95
  • Support Level
  • BCLI $0.33
  • BMTX $2.54
  • Resistance Level
  • BCLI $0.38
  • BMTX $2.89
  • Average True Range (ATR)
  • BCLI 0.03
  • BMTX 0.20
  • MACD
  • BCLI 0.01
  • BMTX 0.08
  • Stochastic Oscillator
  • BCLI 46.90
  • BMTX 93.42

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About BMTX BM Technologies Inc.

BM Technologies Inc provides digital banking and disbursement services to consumers and students nationwide through a full-service fintech banking platform, accessible to customers anywhere and anytime through digital channels. It facilitates deposits and banking services between a customer and its Partner Bank, Customers Bank, which is a related party and is a Federal Deposit Insurance Corporation (FDIC) insured bank. The company has four primary revenue sources: interchange and card revenue, servicing fees, account fees, and university fees. The majority of revenues are driven by customer activity (deposits, spending, transactions, etc.) and may be paid or passed through by customer banks, universities, or paid directly by customers.

Share on Social Networks: